Publication:
Detailed functional analysis of two clinical glucose-6-phosphate dehydrogenase (G6PD) variants, G6PD<inf>Viangchan</inf>and G6PD<inf>Viangchan + Mahidol</inf>: Decreased stability and catalytic efficiency contribute to the clinical phenotype

dc.contributor.authorUsa Boonyuenen_US
dc.contributor.authorKamonwan Chamchoyen_US
dc.contributor.authorThitiluck Swangsrien_US
dc.contributor.authorNaowarat Saralambaen_US
dc.contributor.authorNicholas P.J. Dayen_US
dc.contributor.authorMallika Imwongen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherNuffield Department of Clinical Medicineen_US
dc.date.accessioned2018-12-11T02:14:39Z
dc.date.accessioned2019-03-14T08:04:05Z
dc.date.available2018-12-11T02:14:39Z
dc.date.available2019-03-14T08:04:05Z
dc.date.issued2016-06-01en_US
dc.description.abstract© 2016 The Authors. Deficiency of glucose-6-phosphate dehydrogenase (G6PD) is an X-linked hereditary genetic defect that is the most common polymorphism and enzymopathy in humans. To investigate functional properties of two clinical variants, G6PDViangchanand G6PDViangchan + Mahidol, these two mutants were created by overlap-extension PCR, expressed in Escherichia coli and purified to homogeneity. We describe an overexpression and purification method to obtain substantial amounts of functionally active protein. The KMfor G6P of the two variants was comparable to the KMof the native enzyme, whereas the KMfor NADP+was increased 5-fold for G6PDViangchanand 8-fold for G6PDViangchan + Mahidolwhen compared with the native enzyme. Additionally, kcatof the mutant enzymes was markedly reduced, resulting in a 10- and 18-fold reduction in catalytic efficiency for NADP+catalysis for G6PDViangchanand G6PDViangchan + Mahidol, respectively. Furthermore, the two variants demonstrated significant reduction in thermostability, but similar susceptibility to trypsin digestion, when compared with the wild-type enzyme. The presence of NADP+is shown to improve the stability of G6PD enzymes. This is the first report indicating that protein instability and reduced catalytic efficiency are responsible for the reduced catalytic activity of G6PDViangchanand G6PDViangchan + Mahidoland, as a consequence, contribute to the clinical phenotypes of these two clinical variants.en_US
dc.identifier.citationMolecular Genetics and Metabolism. Vol.118, No.2 (2016), 84-91en_US
dc.identifier.doi10.1016/j.ymgme.2016.03.008en_US
dc.identifier.issn10967206en_US
dc.identifier.issn10967192en_US
dc.identifier.other2-s2.0-84961990524en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/43022
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84961990524&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.titleDetailed functional analysis of two clinical glucose-6-phosphate dehydrogenase (G6PD) variants, G6PD<inf>Viangchan</inf>and G6PD<inf>Viangchan + Mahidol</inf>: Decreased stability and catalytic efficiency contribute to the clinical phenotypeen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84961990524&origin=inwarden_US

Files

Collections